Cite
[Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
MLA
Bałdys-Waligórska, Agata, et al. “[Evaluation of Radioiodine 131I Treatment in Graves’ Disease Patients with Mild Orbitopathy].” Przeglad Lekarski, vol. 66, no. 4, 2009, pp. 166–69. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19708504&authtype=sso&custid=ns315887.
APA
Bałdys-Waligórska, A., Stefańska, A., Gołkowski, F., Sokołowski, G., & Hubalewska-Dydejczyk, A. (2009). [Evaluation of radioiodine 131I treatment in Graves’ disease patients with mild orbitopathy]. Przeglad Lekarski, 66(4), 166–169.
Chicago
Bałdys-Waligórska, Agata, Agnieszka Stefańska, Filip Gołkowski, Grzegorz Sokołowski, and Alicja Hubalewska-Dydejczyk. 2009. “[Evaluation of Radioiodine 131I Treatment in Graves’ Disease Patients with Mild Orbitopathy].” Przeglad Lekarski 66 (4): 166–69. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=19708504&authtype=sso&custid=ns315887.